Physician profile
Kenneth Melton
NPI 1003815994
$1,217.42
in general payments reported to CMS, 2019-2025
17 companies · $31.12 in 2025
The $31.12 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $140 · 2021: $207 · 2022: $360 · 2025: $31.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $342.19 | 2019-2022 | |
| Opko Pharmaceuticals, LLC | $136.11 | 2019-2022 | |
| Vifor Pharma, INC. | $110.29 | 2019-2022 | |
| Amgen INC. | $103.68 | 2019-2022 | |
| Horizon Therapeutics Plc | $102.73 | 2019-2022 | |
| Fresenius USA Marketing, INC. | $74.92 | 2021-2022 | |
| Glaxosmithkline, LLC. | $53.75 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $50.45 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.84 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $40.36 | 2022 | |
| Daiichi Sankyo INC. | $31.93 | 2020-2021 | |
| Aurinia Pharma U.S., INC. | $29.18 | 2022 | |
| Boston Scientific Corporation | $27.84 | 2021-2025 | Spyglass Discover |
| Nxstage Medical, INC. | $23.18 | 2019 | |
| Travere Therapeutics, INC. | $17.38 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $16.94 | 2025 | Abc Handpieces |
| Shire North American Group INC | $15.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Melton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.